Table 1 General characteristics of subjects with the number of EF < 50%
Characteristic | SBT (minutes) | P | |||
|---|---|---|---|---|---|
≤ 120 | 121–240 | 241–360 | ≥ 361 | ||
(n = 31) | (n = 130) | (n = 126) | (n = 92) | ||
Male, n (%) | 25 (80.6) | 101 (77.7) | 98 (77.8) | 70 (76.1) | 0.96 |
Smoking history, n (%) | 19 (61.3) | 65 (50.0) | 55 (43.7) | 39 (42.4) | 0.23 |
Drinking history, n (%) | 12 (38.7) | 33 (25.4) | 34 (27.0) | 7 (7.6) | 0.5 |
DM history, n (%) | 2 (6.5) | 30 (23.1) | 29 (23.0) | 20 (21.7) | 0.21 |
Hypertension history, n (%) | 14 (45.2) | 54 (41.5) | 50 (39.7) | 50 (54.3) | 0.15 |
Myocardial infarction history, n (%) | 1 (3.2) | 12 (9.2) | 13 (10.3) | 8 (8.7) | 0.67 |
Atrial fibrillation history, n (%) | 1 (3.2) | 2 (1.5) | 3 (2.4) | 3 (3.2) | 0.85 |
Killip classification, n (%) | |||||
I | 23 (74.2) | 100 (76.9) | 102 (81.0) | 59 (64.1) | 0.04 |
II | 7 (22.6) | 23 (17.7) | 11 (8.7) | 15 (16.3) | 0.1 |
III | 1 (3.2) | 3 (2.3) | 6 (4.8) | 4 (4.4) | 0.74 |
IV | 0 (0) | 4 (3.1) | 7 (5.5) | 14 (15.2) | 0.001 |
LM, n (%) | 0 (0) | 1 (0.8) | 1 (0.8) | 4 (4.3) | 0.11 |
LAD, n (%) | 20 (64.5) | 77 (59.2) | 70 (55.6) | 47 (51.1) | 0.5 |
LCX, n (%) | 2 (6.5) | 13 (10.0) | 10 (7.9) | 13 (14.1) | 0.43 |
RCA, n (%) | 9 (29.0) | 39 (30.0) | 45 (35.7) | 30 (32.6) | 0.77 |
Grading of thrombus, n (%) | |||||
0 | 0 (0) | 1 (0.8) | 0 (0) | 0 (0) | 0.59 |
1 | 0 (0) | 1 (0.8) | 0 (0) | 1 (1.1) | 0.67 |
2 | 2 (6.5) | 10 (7.7) | 10 (7.9) | 6 (6.5) | 0.97 |
3 | 9 (29.0) | 55 (42.3) | 53 (42.1) | 42 (45.7) | 0.45 |
4 | 18 (58.1) | 44 (33.1) | 36 (28.6) | 26 (28.3) | 0.01 |
5 | 2 (6.4) | 20 (15.3) | 27 (21.4) | 17 (18.4) | 0.21 |
TIMI classification, n (%) | |||||
0 | 0 (0) | 0 (0) | 1 (0.8) | 5 (5.4) | 0.008 |
1 | 0 (0) | 0 (0) | 0 (0) | 3 (3.3) | 0.02 |
2 | 1 (3.2) | 13 (10.0) | 10 (7.9) | 11 (12.0) | 0.47 |
3 | 30 (96.8) | 117 (90.0) | 116 (91.3) | 73 (79.3) | 0.13 |
Slow flow, n (%) | 2 (6.5) | 18 (13.8) | 14 (11.1) | 20 (21.7) | 0.08 |
VF, n (%) | 1 (3.2) | 5 (3.8) | 4 (3.2) | 2 (2.2) | 0.92 |
Application of IABP, n (%) | 0 (0) | 4 (3.1) | 7 (5.6) | 8 (8.7) | 0.15 |
Administration of β-blocker, n (%) | 22 (71.0) | 98 (75.4) | 81 (64.3) | 50 (54.3) | 0.01 |
ACEI/ARB, n (%) | 19 (61.3) | 74 (56.9) | 59 (46.8) | 35 (38.0) | 0.02 |
Administration of diuretic, n (%) | 10 (32.3) | 32 (24.6) | 35 (27.8) | 27 (29.3) | 0.79 |
Administration of nicorandil, n (%) | 7 (22.6) | 16 (12.3) | 14 (11.1) | 6 (6.5) | 0.11 |
AKI, n(%) | 3 (9.7) | 8 (6.2) | 7 (5.6) | 15 (16.3) | 0.04 |
Age, years, mean ± SD | 60.06 ± 15.36 | 60.62 ± 11.44 | 60.14 ± 11.99 | 63.10 ± 11.01 | 0.28 |
BMI, kg/m2, mean ± SD | 25.62 ± 3.89 | 25.57 ± 3.83 | 25.08 ± 3.34 | 25.41 ± 3.60 | 0.72 |
Symptom-to-door time, minutes, mean ± SD | 34.94 ± 19.18 | 88.57 ± 39.34 | 137.52 ± 73.03 | 236.72 ± 155.35 | 0.001 |
P, bpm, mean ± SD | 75.77 ± 17.81 | 76.44 ± 15.94 | 75.53 ± 14.97 | 75.68 ± 19.51 | 0.96 |
SBP, mmHg, mean ± SD | 131.90 ± 23.90 | 131.43 ± 25.16 | 123.24 ± 23.61 | 119.67 ± 28.76 | 0.002 |
DBP, mmHg, mean ± SD | 81.61 ± 14.31 | 81.34 ± 13.34 | 76.36 ± 14.48 | 73.25 ± 17.20 | 0.001 |
Length of lesion, mm, mean ± SD | 24.90 ± 7.35 | 30.55 ± 10.98 | 28.59 ± 9.72 | 29.97 ± 11.62 | 0.04 |
Syntax score, mean ± SD | 21.26 ± 6.60 | 22.27 ± 8.30 | 22.65 ± 8.06 | 23.94 ± 8.90 | 0.34 |
WBC, 109/L, mean ± SD | 10.83 ± 4.86 | 10.45 ± 3.04 | 11.07 ± 3.94 | 11.32 ± 3.40 | 0.32 |
RBC, 1012/L, mean ± SD | 4.64 ± 0.55 | 4.52 ± 0.57 | 4.53 ± 0.65 | 4.48 ± 0.58 | 0.66 |
HGB, g/L, mean ± SD | 144.85 ± 19.42 | 139.76 ± 17.61 | 141.30 ± 18.20 | 139.14 ± 18.20 | 0.43 |
PLT, 109/L, mean ± SD | 228.88 ± 53.25 | 218.05 ± 58.11 | 230.72 ± 62.61 | 229.07 ± 67.13 | 0.36 |
K, mmol/L, mean ± SD | 4.03 ± 0.64 | 4.05 ± 0.47 | 3.99 ± 0.46 | 4.08 ± 0.50 | 0.56 |
Na, mmol/L, mean ± SD | 138.48 ± 2.76 | 138.54 ± 3.38 | 138.74 ± 3.00 | 139.09 ± 4.15 | 0.67 |
Cl, mmol/L, mean ± SD | 104.25 ± 2.37 | 102.29 ± 7.23 | 102.30 ± 3.34 | 101.44 ± 8.15 | 0.19 |
Cr, µmol/L, mean ± SD | 83.60 ± 51.03 | 74.24 ± 20.31 | 74.83 ± 23.76 | 77.63 ± 29.77 | 0.33 |
UA, µmol/L, mean ± SD | 335.20 ± 94.89 | 307.62 ± 87.65 | 312.18 ± 75.66 | 330.02 ± 105.64 | 0.17 |
CHOL, mmol/L, mean ± SD | 4.54 ± 1.16 | 4.58 ± 0.97 | 4.61 ± 1.00 | 4.24 ± 1.00 | 0.05 |
TG, mmol/L, mean ± SD | 1.44 ± 0.73 | 1.55 ± 1.17 | 1.65 ± 1.03 | 1.59 ± 0.79 | 0.71 |
HDL, mmol/L, mean ± SD | 1.02 ± 0.22 | 1.04 ± 0.24 | 1.03 ± 0.37 | 1.01 ± 0.23 | 0.82 |
LDL, mmol/L, mean ± SD | 3.03 ± 0.82 | 2.90 ± 0.73 | 2.93 ± 0.74 | 2.81 ± 0.69 | 0.45 |
CK-MB, ng/mL, mean ± SD | 200.34 ± 108.59 | 185.11 ± 95.02 | 185.27 ± 98.24 | 201.82 ± 104.59 | 0.53 |
GLU, mmol/L, mean ± SD | 7.56 ± 2.60 | 8.28 ± 3.29 | 8.73 ± 3.67 | 8.84 ± 3.86 | 0.25 |